Get started
Author

Matilde Calopa

Observed names: Calopa, Matilde, M Calopa, M. Calopa, M. Calopa Garriga, Matil Calopa, Matilde Calopa Garniga, Matilde Calopa Garride, Matilde Calopa Garriga, Màtil Calopa
Observed institutions: Institució Catalana de Recerca i Estudis Avançats, Universitat Autònoma de Barcelona, Bellvitge University Hospital, Biomedical Research Networking Center on Neurodegenerative Diseases, Institut d'Investigació Biomédica de Bellvitge, University Hospital Mútua de Terrassa, Hospital Clínic de Barcelona, Vall d'Hebron Hospital Universitari, Universitat de Barcelona
ORCID: 0000-0002-6943-3707
Observed ORCID: 0000-0002-6943-3707
OpenAlex ID: A5002795392
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
2012 · J.-M. Lee, E.M. Ramos, et al. · Neurology · 382
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
2017 · Davina J Hensman Moss, Antonio F Pardiñas, et al. · The Lancet Neurology · 310
PDF
Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
2008 · Pedro J. García Ruiz, Ángel Sesar Ignacio, et al. · Movement Disorders · 234
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
2017 · Angelo Antonini, Werner Poewe, et al. · Parkinsonism & Related Disorders · 220
PDF
Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia
2010 · Cristina Sanchez‐Castaneda, Ramon Rene, et al. · Movement Disorders · 127
Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry
2015 · Maríateresa Buongiorno, Francesca Antonelli, et al. · Parkinsonism & Related Disorders · 91
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers
2015 · Claustre Pont-Sunyer, Alex Iranzo, et al. · PLoS ONE · 89
PDF
Apoptosis of peripheral blood lymphocytes in Parkinson patients
2010 · Màtil Calopa, Jordi Bas, et al. · Neurobiology of Disease · 81
Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
2014 · Carles Gaig, Dolores Vilas, et al. · PLoS ONE · 79
PDF
Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia
2009 · Cristina Sanchez‐Castaneda, Ramon Rene, et al. · Movement Disorders · 77
Significant Changes in the Tau A0 and A3 Alleles in Progressive Supranuclear Palsy and Improved Genotyping by Silver Detection
1998 · Rafael Oliva, Eduardo Tolosa, et al. · Archives of Neurology · 70
Further extension of the H1 haplotype associated with progressive supranuclear palsy
2002 · Pau Pastor, Mario Ezquerra, et al. · Movement Disorders · 67
Validation of a Portable Device for Mapping Motor and Gait Disturbances in Parkinson’s Disease
2015 · Alejandro Rodríguez-Molinero, Albert Samà, et al. · JMIR mhealth and uhealth · 64
PDF
Nigral and striatal connectivity alterations in asymptomatic LRRK2 mutation carriers: A magnetic resonance imaging study
2016 · Dolores Vilas, Bàrbara Segura, et al. · Movement Disorders · 57
Clinical manifestations of intermediate allele carriers in Huntington disease
2016 · Esther Cubo, María A. Ramos-Arroyo, et al. · Neurology · 53
Discovering the 3′ UTR-mediated regulation of alpha-synuclein
2017 · Domenica Marchese, Teresa Botta-Orfila, et al. · Nucleic Acids Research · 47
PDF
White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease
2019 · Audrey E. De Paepe, Joanna Sierpowska, et al. · NeuroImage Clinical · 46
PDF
Electrophysiological study of ephaptic axono‐axonal responses in hemifacial spasm
2006 · J. Montero, J. Junyent, et al. · Muscle & Nerve · 45
Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study
2019 · Yaroslau Compta, Sara P. Dias, et al. · Parkinsonism & Related Disorders · 42
PDF
Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer’s disease
2007 · Beatrice Terni, María Jesús Rey, et al. · Acta Neuropathologica · 42
Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy
2017 · Yaroslau Compta, Darly M. Giraldo, et al. · Parkinsonism & Related Disorders · 41
Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers
2015 · Dolores Vilas, Lourdes Ispierto, et al. · Parkinsonism & Related Disorders · 38
Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants
2012 · Teresa Botta-Orfila, Mario Ezquerra, et al. · Journal of Molecular Neuroscience · 37
Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study
2018 · Paul McNulty, Richard Pilcher, et al. · Journal of Huntington s Disease · 35
Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy
2009 · Mario Ezquerra, Pau Pastor, et al. · Neurobiology of Aging · 35
Works count: 96
Citation count: 2,910
H-index: 27
I10-index: 49
Year
Topic
Type